Neoadjuvant therapies for hepatocellular
✍
Patricia M. Lopez; Augusto Villanueva; Sasan Roayaie; Josep M. Llovet
📂
Article
📅
2006
🏛
John Wiley and Sons
🌐
English
⚖ 133 KB
Hepatocellular carcinoma (HCC) is a major health problem, being the fifth most common cancer worldwide. 1 The incidence of HCC is increasing in Europe and the United States, 2 and it is currently the leading cause of death among patients with cirrhosis. 3 The advent of surveillance programs has led